Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia.
暂无分享,去创建一个
[1] A. Egeberg. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. , 2016, The New England journal of medicine.
[2] M. Liedtke,et al. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. , 2016, The New England journal of medicine.
[3] C. Bennett,et al. Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. , 2016, Leukemia research.
[4] Asma A. Khan,et al. Acetaminophen Old Drug, New Issues , 2015 .
[5] C. Bennett,et al. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. , 2007, Leukemia research.
[6] M. Loriot,et al. Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism , 2006, Clinical pharmacology and therapeutics.
[7] D. Dinsdale,et al. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. , 2005, The international journal of biochemistry & cell biology.
[8] G. Graham,et al. Mechanism of Action of Paracetamol , 2005, American journal of therapeutics.
[9] P. Richardson,et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. , 2003, Blood.
[10] G. McDonald,et al. Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy. , 2002, Blood.
[11] Fernando Holguin,et al. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. , 2009, The Journal of allergy and clinical immunology.